Comparing inflammation markers in blood spot vs. vein blood samples
Part of Immune system & allergy clinical trials.
This trial compares two ways of measuring inflammation in the blood: a finger-prick blood spot and a standard blood draw. It may be a good fit if you are getting a seasonal vaccine or have a planned event that causes temporary inflammation, like intense exercise or a change in medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You plan to get a seasonal vaccine or have a planned stressful event (like a hard workout, a social event with alcohol, starting your period, or a medication change)
- You have not had any symptoms of infection (fever, cough, sore throat, diarrhea, loss of smell or taste) in the last week
- You do not currently use cocaine, injection drugs, or amphetamines
- You have not had a sudden worsening of a chronic condition (like asthma, COPD, or arthritis) in the last month
- You are not severely allergic to the vaccine you will receive
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how aging affects inflammation in the body. It aims to understand why older people have more inflammation, which may lead to age-related diseases. Participating may help researchers develop new ways to reduce inflammation and slow down aging.
This study measures blood “biomarkers” (signals in blood) to better understand inflammatory diseases, including autoimmune and autoinflammatory conditions. You may be asked to give blood samples now and possibly extra samples if needed for testing.
This study collects small blood samples to help test and improve new diagnostic devices. You may be eligible if you’re an adult with certain symptoms that match one of several health “groups,” and if you can consent and read English.
This study looks at blood “biomarkers,” or measurable body signals, in people with autoimmune diseases, vasculitis, or autoinflammatory conditions. The goal is to better understand these illnesses and how they relate to disease activity.
This study looks at how inflammation in the body may affect doctors' thinking and treatment choices. As part of the study, you would receive a flu vaccine, and researchers will measure your body's response and how it might influence your medical decisions.
This study looks at blood vessel cells in three groups: healthy adults, patients having major surgery, and critically ill patients with sepsis. It aims to understand how these cells change in different types of inflammation.
Hear when a new Inflammation Biomarkers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.